UBE3C restricts EV-A71 replication by ubiquitination-dependent degradation of 2C
Journal of Virology · 2024
DOI: 10.1128/jvi.01335-24 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Virology, 2024. Verfasst von Boming Cui und 6 weiteren Autor:innen. Beteiligte Einrichtung: CAMS Key Laboratory of Antiviral Drug Research, Beijing Key Laboratory of Antimicrobial Agents, NHC Key Laboratory of Biotechnology of Antibiotics, I…. Hauptthemen laut MEDLINE: Virus Replication, Ubiquitination, Ubiquitin-Protein Ligases, Enterovirus A, Human. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: CAMS Innovation Fund for Medicinal Sciences, MOST | National Natural Science Foundation of China (NSFC).
Abstract (Originalsprache)
Ubiquitin modification of viral proteins to degrade or regulate their function is one of the strategies of the host to resist viral infection. Here, we report that ubiquitin protein ligase E3C (UBE3C), an E3 ubiquitin ligase, displayed inhibitory effects on EV-A71 replication. UBE3C knockdown resulted in increased viral protein levels and virus titers, whereas overexpression of UBE3C reduced EV-A71 replication. To explore the mechanism by which UBE3C affected EV-A71 infection, we found that the C-terminal of UBE3C bound to 2C protein and facilitated K33/K48-linked ubiquitination degradation of 2C K268. Moreover, UBE3C lost its ability to degrade 2C K268R and had a diminished inhibitory impact against the replication of recombinant EV-A71-FY-2C K268R. In addition, UBE3C also promoted ubiquitination degradation of the 2C protein of CVB3 and CVA16 and inhibited viral replication. Thus, our findings reveal a novel mechanism that UBE3C acts as an enterovirus host restriction factor, including EV-A71, by targeting the 2C protein. IMPORTANCE The highly conserved 2C protein of EV-A71 is a multifunctional protein and plays a key role in the replication cycle. In this study, we demonstrated for the first time that UBE3C promoted the degradation of 2C K268 via K33/K48-linked ubiquitination, thereby inhibiting viral proliferation. Our findings advance the knowledge related to the roles of 2C in EV-A71 virulence and the ubiquitination pathway in the host restriction of EV-A71 infection.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- CAMS Key Laboratory of Antiviral Drug Research, Beijing Key Laboratory of Antimicrobial Agents, NHC Key Laboratory of Biotechnology of Antibiotics, Institute of Medicinal Biotechnology, Chinese Academy of Medical Scienc…
- State Key Laboratory of Bioactive Substances and Functions of Natural Medicines, Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
ORCID-Profile: Huiqiang Wang, Yuhuan Li
Förderung
- CAMS Innovation Fund for Medicinal Sciences
- MOST | National Natural Science Foundation of China (NSFC)
Zitieren
APA
Cui, B., Yang, G., Yan, H., Wu, S., Wang, K., Wang, H., & Li, Y. (2024). UBE3C restricts EV-A71 replication by ubiquitination-dependent degradation of 2C. Journal of Virology. https://doi.org/10.1128/jvi.01335-24
Vancouver
Cui B, Yang G, Yan H, Wu S, Wang K, Wang H, et al. UBE3C restricts EV-A71 replication by ubiquitination-dependent degradation of 2C. Journal of Virology. 2024. doi:10.1128/jvi.01335-24
BibTeX
@article{Cui2024,
author = {Cui, Boming and Yang, Ge and Yan, Haiyan and Wu, Shuo and Wang, Kun and Wang, Huiqiang and Li, Yuhuan},
title = {UBE3C restricts EV-A71 replication by ubiquitination-dependent degradation of 2C},
journal = {Journal of Virology},
year = {2024},
doi = {10.1128/jvi.01335-24}
}
EUVIMED